E-LIB Suche - Ergebnisse für: Avrillon, V.

1

Lorlatinib for advanced ROS1+ non-small-cell lung cancer: r..:

Girard, N. ; Galland-Girodet, S. ; Avrillon, V....
ESMO Open. 7 (2022) 2 - p. 100418 , 2022

Link: https://doi.org/10.1016/..

2

Immune checkpoint inhibitor treatment of a first cancer is ..:

Heudel, P. ; Chabaud, S. ; Perol, D....
ESMO Open. 6 (2021) 1 - p. 100044 , 2021

Link: https://doi.org/10.1016/..

3

Premières données épidémiologiques sur les pneumopathies de..:

Avrillon, V. ; Ny, C. ; Chan, S...
Revue de Pneumologie Clinique. 70 (2014) 3 - p. 133-141 , 2014

Link: https://doi.org/10.1016/..

4

Comment appliquer les recommandations de bonnes pratiques d..:

Couraud, S. ; Chan, S. ; Avrillon, V....
Revue de Pneumologie Clinique. 69 (2013) 5 - p. 244-249 , 2013

Link: https://doi.org/10.1016/..

5

Améliorer la prise en charge des patients par une vidéoconf..:

Couraud, S. ; Chan, S. ; Avrillon, V...
Revue de Pneumologie Clinique. 69 (2013) 2 - p. 119-120 , 2013

Link: https://doi.org/10.1016/..

6

Lorlatinib for advanced ROS1+ non-small-cell lung cancer: r..:

Girard, N ; Galland-Girodet, S ; Avrillon, V...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058895/. , 2022

Link: http://www.ncbi.nlm.nih...

7

A definitive prognostication system for patients with thora..:

Whisenant, JG ; Baena, J ; Cortellini, A...
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2022. , 2022

Link: https://repository.icr.a..

8

A Definitive Prognostication System for Patients With Thora..:

Whisenant, J.G ; Baena, J ; Cortellini, A...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jtho.2021.12.015. , 2022

Link: https://serval.unil.ch/n..

9

Immune checkpoint inhibitor treatment of a first cancer is ..:

Heudel, P ; Chabaud, S ; Perol, D...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.esmoop.2020.100044. , 2021

Link: https://hal.science/hal-..

10

Immune checkpoint inhibitor treatment of a first cancer is ..:

Heudel, P ; Chabaud, S ; Perol, D...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.esmoop.2020.100044. , 2021

Link: https://hal.science/hal-..

11

Immune checkpoint inhibitor treatment of a first cancer is ..:

Heudel, P ; Chabaud, S ; Perol, D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844579/. , 2021

Link: http://www.ncbi.nlm.nih...

12

Immune checkpoint inhibitor treatment of a first cancer is ..:

Heudel, P ; Chabaud, S ; Perol, D...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.esmoop.2020.100044. , 2021

Link: https://hal.science/hal-..

13

Immune checkpoint inhibitor treatment of a first cancer is ..:

Heudel, P ; Chabaud, S ; Perol, D...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.esmoop.2020.100044. , 2021

Link: https://hal.science/hal-..

14

Monsieur de Talleyrand:

, In: Monsieur de Talleyrand / [Charles Maxime de Villemarest]
Bd. 4,

Villemarest, Charles Maxime de ; Talleyrand-Périgord, Charles Maurice de , 1835

Exemplar: Zentrale:Magazin 02.f.8825

15

Monsieur de Talleyrand:

, In: Monsieur de Talleyrand / [Charles Maxime de Villemarest]
Bd. 3,

Villemarest, Charles Maxime de ; Talleyrand-Périgord, Charles Maurice de , 1835

Exemplar: Zentrale:Magazin 02.f.8824